George Yardy Consultant Urological Surgeon the Ipswich Hospital, ESNEFT Topics Covered

Total Page:16

File Type:pdf, Size:1020Kb

George Yardy Consultant Urological Surgeon the Ipswich Hospital, ESNEFT Topics Covered Urology and Men’s Health 17th June 2021 George Yardy Consultant Urological Surgeon The Ipswich Hospital, ESNEFT Topics covered • Male LUTS – Case study – Medication – surgery • Covid and urology • Female incontinence and UTI – Case study – Catheters – Botox • General paediatric urology – Foreskin – Groin • Bladder pain syndrome / chronic prostatitis / chronic pelvic pain syndrome • Vasectomy reversal Male LUTS: case study Mr C.W., 72 y.o. 20/06/2017 Male LUTS / prostate assessment clinic I yr urgency, frequency, nocturia x6, occ urge urinary incontinence No better with tamsulosin Satis. erectile fn. PMH: hypertension, hernia repair DH: atorvastatin, losartan RE: moderate (60g?) benign prostate PSA 5.3, Creatinine 104, urine dip NAD Male LUTS: case study • IPSS 20/35, QoL 5/6 • Frequency / volume chart: – Total 14 – 18 voids / 24h – Intake 4000ml / day Male LUTS: case study • 19/07/2017 Urodynamics Male LUTS: case study • 19/07/2017 Urodynamics Impression: Equivocal bladder outlet obstruction, no detrusor overactivity, empties fully. Ie. “sensory urge” Male LUTS: case study • 07/08/2018 flexible cystoscopy – large occlusive prostate, bladder normal • 12/02/2019 brought in for TURP but cancelled – c/o esp. urgency, some urge inco, not had med for this LUTS termiology Lower urinary tract symptoms (LUTS) are storage, voiding and postmicturition symptoms affecting the lower urinary tract. Bothersome LUTS may occur in up to 30% of men older than 65 years. Storage Post Voiding (previously ‘irritative’) (previously ‘obstructive’) Micturition weak or intermittent urgency urinary stream dribbling frequency straining incontinence hesitancy Nocturia terminal dribbling incomplete emptying BPH and Progression Anatomy of BPH NormalBPH Bladder Hypertrophied Prostate detrusor muscle Urethra Obstructed Adapted from Kirby RS et al. Benign Prostatic urinary flow Hyperplasia.Health Press 1999 Medication for LUTS • α blockers – Tamsulison, Alfuzosin – “uroselective” – Work quickly – days – s/e.s – dizzy (first doses?), ejaculatory dysfunction • 5 α-reductase inhibitors – Finasteride, Dutasteride – Works only for larger prostates – Effect takes 3-6 months – s/e.s - libido, erections • Combination α blocker / 5ARI – Decreases risk of progression (worsening IPSS, retention sugery) – If at risk (large prostate, PSA >1.4, IPSS >10 • PDE5 inhibitors – Some evidence of common pathophysiology of ED and LUTS – More relevant now generic Tadalafil available? Medication for LUTS • Antimuscarinics – Low risk of retention if residual >200ml – Side effects – Generic Tolterodine, Solifenacin • Β3 agonist – Mirabegron seems as effective as antimuscarinic, without side effects Male LUTS: case study • Some improvement with tolterodine and physio • Repeat UDS 11/09/20 Definite bladder outlet obstruction, Minor detrusor overactivity Listed for TURP Start finasteride to decrease intra-operative bleeding Surgical options • “Cavitating procedures” – TURP – Laser operations • “MIST” – minimally invasive surgical therapy – Urolift – prostatic urethral lift – Rezum – steam – PAE – prostate artery embolisation – iTIND – others on the way Conventional TURP • Established “gold standard” – National Prostatectomy Audit BJUi 1995 • Monopolar diathermy – Affects pacemaker? • Glycine irrigation – Resection time limited to 1 hour – Or else “TUR syndrome” – fluid overload, hyponatraemia, neurotoxic metabolites Bipolar TURP • Mechanistically similar to TURP • Bipolar diathermy energy • Saline irrigation • Allows longer resection • Better haemostasis / less blood loss • No TUR syndrome “TURis” – transurethral resection in saline = Olympus PLASMA System Introducing The UroLift® System Treatment 1. The UroLift delivery 2. UroLift implants are placed through a needle that 3. The UroLift delivery device is placed through comes out of the delivery device to lift the device is removed, the urethra to access enlarged prostate tissue out of the way. leaving a more open the enlarged prostate. urethra. The UroLift ® System directly opens the urethra without prostate tissue removal or ablation. 20 The UroLift® System • Single-use device • CE marked, TGA approved and now with a positive, finalized NICE guidance: – Indicated for the treatment of symptoms due to urinary outflow obstruction secondary to BPH in men over the age of 50. Delivery device UroLift System Implant U.S. Patents: 7,645,286; 7,758,594; 7,766,923; 7,905,889; 8,007,503 21 UroLift® System Is A Whole New Approach PRE POST • Immediately opens the prostatic urethra • Can treat LUTS without compromising normal prostate function • Provides rapid relief without complications from prostate injury • Opens up a new option for urologists and patients *Data on file at NeoTract, Inc. 22 •Day case •No catheter •Small / medium prostate •No ejaculatory dysfunction Prostate Aretry Embolisation • Embolisation already established eg for refractory pelvic bleeding, fibroids • Local anaesthesia, X-ray guidance • Groin approach -> femoral artery -> Super- selective catheterisation of small prostatic arteries • Embolisation with microparticles via fine microcatheters • Necrosis and shrinking of prostate PAE • Where does it fit in our BPH pathway? • Complex but safe procedure • Men who wish to avoid or at least delay surgery but accept inferior symptom improvement and effect may be temporary • Nigel Hacking, Interventional Radiologist, Southampton Rezum • Steam / radiofrequency energy to ablate tissue • Prostate up to 80g • Transurethral • GA or sedation • Up to 20 minute procedure, day case • Catheter 4-7 days • No ED, little retrograde ejac Summary of surgical options • Cavitating procedures – Treat large prostates, severe symptoms – Significant improvement in sx, for long duration – low reoperation rate – Longer hospital stay and recovery • MIST – Now accumulating experience nationally and locally – Short procedures, quicker recovery, lower sexual side effects – Do not improve sx as much, may require further procedure later Male LUTS: case study •28/04/21 uneventful TURP 21g resected, histology benign •clinic 09/06/21 Pleased Flow better Nocturia x3 (was x6) OAB symptoms likely to settle further over months Covid • effects of Covid on urinary tract • effects of Covid on urological services • prioritisation categories Effects of Covid on urinary tract Bladder and kidney at risk of invasion ▪ SARS-CoV-2 spike protein binds to ACE2 receptors – detected on cells of kidney and bladder ▪ contribute to AKI in Covid +/- septic shock, cytokine storm, immune mech.s Viral RNA • 6.9% Covid patients, remains positive after throat swab returns neg • but 0% in another study No report of transmission to hospital staff via urine / bladder irrigation fluid Effect of Covid on urological services Adapt, prioritise, delay, recover Virtual clinics – great for some follow-ups, impossible for many new patients Referral delays England 2WW suspected urological cancer referral Feb 2020: 18,534 Apr 2020: 7,859 (58% reduction) 3/12 delay to diagnosis 10% 10 yr survival for bladder cancer little change for prostate / testis cancer Risk prioritisation Theatre delays Nosocomial infection Operative prioritisation • Priority 1a: <24h – Obstructed infected kidney – Uncontrolled haematuria – Fourniere gangrene • Priority 1b: <72h – Upper urinary tract obstruction – Acute stones with pain / renal impairment – Penile # Operative prioritisation • Priority 2: < 1/12 – Some MDT-directed bladder / renal cancer – Ureteroscopy for stones with stents – Visible haematuria investigation • Priority 3: <3/12 – High / intermediate risk prostate cancer – Bladder outlet surgery in catheterised males – Non-visible haematuria investigation – Stent change – Orchidopexy for undescended testis Operative prioritisation • Priority 4: >3/12 – Benign female incontinence – Uncomplicated stone surgery – ED, infertility – Low risk prostate cancer, superficial TCC – Bladder outlet surgery – TURP – Benign penoscrotal surgery Case study: female with MS and urinary symptoms • Mrs MM. 55 yrs old • MS diagnosed 1989 – optic neuritis, right arm weakness • 2007 weak left side of body, back pain, tingling & spasms both legs • 2008 short period in wheelchair • Fluctuating, slowly progressive, unsteady walking • Received treatments inc Avonex, Copaxone, Tecfidera, pregabalin, baclofen • Bladder overactivity initially controlled with oxybutinin Case study: female with MS and urinary symptoms: UTI • 2015 also recurrent UTI – Rx 6/12 continuous trimethoprim – Then “self-start” ABx • 2016 Rx methenamine • 2018 Cystistat Some general comments about recurrent UTI • USS worthwhile but cystoscopy rarely contributory in neurologically normal pre-menopausal female • Men need flow rate +/- cystoscopy +/- Rx for chronic prostatitis • Lifestyle advice: leaflet from RCGP / BAUS / patient.info • Topical (intravaginal) oestrogen • D-mannose (vs cranberry, lactobacillus) Some general comments about recurrent UTI • Antibiotics – Standby / self start – Trigger (eg. post-coital) – Continuous prophylactic • Resistance • Review at least 6 months • Not at all keen on “rotational” ABx • Methenamine – “Hiprex” – Large tablet b.d., tastes of vinegar – Metabolised to formaldehyde in acidic urine – Surprisingly well-tolerated! • Other (secondary care) – Instillations – Cystistat, Hyacyst Case study: female with MS and urinary symptoms: catheters • 2011 started intermittent self-catheterisation (ISC) – ISC frequently reqd in incomplete bladder emptying in MS – Rarely required after Botox in neurologically normal females • 2016 constant bladder
Recommended publications
  • Spring 06 2 27.Qxp
    University of California, Irvine School of Medicine Spring 2006 UCI Medical Center Department of Urology 101 THE CITY DRIVE SOUTH ORANGE, CA 92868-5395 N E W S L E T T E R Re-United: The facts about vasectomy reversal "When a man consents to undergo a vasectomy, he is usually instructed that the procedure should be considered Aaron Spitz, MD to be permanent and irreversible.... Nonetheless, even the Assistant Clinical Professor Male Reproductive Medicine most insightful, thoughtful decision can ultimately prove and Surgery wrong. When that decision is a vasectomy, a man may still change his mind." re you considering a vasec- tomy. Therefore, before undergoing a tomy reversal? Thousands vasectomy, a man should be as sure as A of men undergo vasectomy possible that he is finished having chil- each year as a permanent means of dren. Nonetheless, even the most birth control, yet for some of these men insightful, thoughtful decision can ulti- life brings unexpected turns, which mately prove wrong. When that deci- leads them to change their mind. For sion is a vasectomy, a man may still Epididymo-vasostomy some, there is a strong desire to have change his mind. sperm travel from the testicle to the another child a few years later. For urethra. It feels like a piece of under- others, there may be a tragic loss of a What is a vasectomy? cooked spaghetti in each side of the child. For many men, a new marriage To understand the vasectomy reversal, scrotum. The sperm are produced in brings a new opportunity for creating a it is important to understand the vasec- the testicle, and then they exit out the family.
    [Show full text]
  • Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1
    Crack Cast Show Notes – Urological Disorders – August 2017 www.crackcast.org Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1. Differentiate between the three major causes of dysuria in women? (ddx of dysuria) 2. List 3 common UTI pathogens, and list 3 additional pathogens in complicated UTIs 3. Define uncomplicated UTI and antibiotic options 4. Define complicated UTI and antibiotic options 5. List two antibiotic options for uncomplicated and complicated pyelonephritis. 6. How is pyelonephritis managed in pregnancy? What are safe antibiotic options for bacteriuria in pregnancy? Prostatitis 1. Describe the diagnosis and management of prostatitis Renal Calculi 1. Name the areas of narrowing in the ureter 2. Name 6 risk factors for urolithiasis 3. List 8 alternative diagnoses (other than renal colic) for pain associated with urolithiasis 4. What are indications for hospitalization of patients with urolithiasis Bladder (Vesical) Calculi 1. Describe this condition and its management Acute Scrotal Pain 1. List causes of acute scrotal swelling by age groups (infant, child, adolescent, adult) 2. Describe the physiology, diagnosis and management of testicular torsion 3. Describe the treatment for sexually vs. non-sexually acquired epididymitis Acute Urinary Retention 1. Describe the physiology of urination 2. List 10 causes of acute urinary retention in adults 3. List 6 causes of urinary retention in women Hematuria 1. List causes of red-coloured urine without hematuria 2. List risk factors for urinary tract malignancy Wisecracks: 1. When is a urine culture indicated (box 89.1) 2. What is a CAUTI and how is it managed? 3. What are two medication classes of drugs for prostatic enlargement? 4.
    [Show full text]
  • Urology Services in the ASC
    Urology Services in the ASC Brad D. Lerner, MD, FACS, CASC Medical Director Summit ASC President of Chesapeake Urology Associates Chief of Urology Union Memorial Hospital Urologic Consultant NFL Baltimore Ravens Learning Objectives: Describe the numerous basic and advanced urology cases/lines of service that can be provided in an ASC setting Discuss various opportunities regarding clinical, operational and financial aspects of urology lines of service in an ASC setting Why Offer Urology Services in Your ASC? Majority of urologic surgical services are already outpatient Many urologic procedures are high volume, short duration and low cost Increasing emphasis on movement of site of service for surgical cases from hospitals and insurance carriers to ASCs There are still some case types where patients are traditionally admitted or placed in extended recovery status that can be converted to strictly outpatient status and would be suitable for an ASC Potential core of fee-for-service case types (microsurgery, aesthetics, prosthetics, etc.) Increasing Population of Those Aged 65 and Over As of 2018, it was estimated that there were 51 million persons aged 65 and over (15.63% of total population) By 2030, it is expected that there will be 72.1 million persons aged 65 and over National ASC Statistics - 2017 Urology cases represented 6% of total case mix for ASCs Urology cases were 4th in median net revenue per case (approximately $2,400) – behind Orthopedics, ENT and Podiatry Urology comprised 3% of single specialty ASCs (5th behind
    [Show full text]
  • Clinical Significance of Cystoscopic Urethral Stricture
    UCSF UC San Francisco Previously Published Works Title Clinical significance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi-institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS). Permalink https://escholarship.org/uc/item/3f57n621 Journal World journal of urology, 37(12) ISSN 0724-4983 Authors Baradaran, Nima Fergus, Kirkpatrick B Moses, Rachel A et al. Publication Date 2019-12-01 DOI 10.1007/s00345-019-02653-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California World Journal of Urology https://doi.org/10.1007/s00345-019-02653-6 ORIGINAL ARTICLE Clinical signifcance of cystoscopic urethral stricture recurrence after anterior urethroplasty: a multi‑institution analysis from Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Nima Baradaran1 · Kirkpatrick B. Fergus2 · Rachel A. Moses3 · Darshan P. Patel3 · Thomas W. Gaither2 · Bryan B. Voelzke4 · Thomas G. Smith III5 · Bradley A. Erickson6 · Sean P. Elliott7 · Nejd F. Alsikaf8 · Alex J. Vanni9 · Jill Buckley10 · Lee C. Zhao11 · Jeremy B. Myers3 · Benjamin N. Breyer2 Received: 13 December 2018 / Accepted: 24 January 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Purpose To assess the functional Queryoutcome of patients with cystoscopic recurrence of stricture post-urethroplasty and to evaluate the role of cystoscopy as initial screening tool to predict future failure. Methods Cases with cystoscopy data after anterior urethroplasty in a multi-institutional database were retrospectively studied. Based on cystoscopic evaluation, performed within 3-months post-urethroplasty, patients were categorized as small-caliber (SC) stricture recurrence: stricture unable to be passed by standard cystoscope, large-caliber (LC) stricture accommodating a cystoscope, and no recurrence.
    [Show full text]
  • Bladder Cancer
    Clinical Practice in Urology Series Editor: Geoffrey D. Chisholm Titles in the series already published Urinary Diversion Edited by Michael Handley Ashken Chemotherapy and Urological Malignancy Edited by A. S. D. Spiers Urodynamics Paul Abrams, Roger Feneley and Michael Torrens Male Infertility Edited by T. B. Hargreave The Pharmacology of the Urinary Tract Edited by M. Caine Forthcoming titles in the series Urological Prostheses, Appliances and Catheters Edited by J. P. Pryor Percutaneous and Interventional Uroradiology Edited by Erich K. Lang Adenocarcinoma of the Prostate Edited by Andrew W. Bruce and John Trachtenberg Bladder Cancer Edited by E. J. Zingg and D. M. A. Wallace With 50 Figures Springer-Verlag Berlin Heidelberg New York Tokyo E. J. Zingg, MD Professor and Chairman, Department of Urology, Univ~rsity of Berne, Inselspital, 3010 Berne, Switzerland D. M. A. Wallace, FRCS Consultant Urologist, Department of Urology, Queen Elizabeth Medical Centre, Birmingham, England Series Editor Geoffrey D. Chisholm, ChM, FRCS, FRCSEd Professor of Surgery, University of Edinburgh; Consultant Urological Surgeon, Western General Hospital, Edinburgh, Scotland ISBN -13: 978-1-4471-1364-5 e-ISBN -13: 978-1-4471-1362-1 DOI: 10.1007/978-1-4471-1362-1 Library of Congress Cataloging in Publication Data Main entry under title: Bladder Cancer (Clinical Practice in Urology) Includes bibliographies and index. 1. Bladder - Cancer. I. Zingg, Ernst J. II. Wallace, D.M.A. (David Michael Alexander), 1946- DNLM: 1. Bladder Neoplasms. WJ 504 B6313 RC280.B5B632 1985 616.99'462 85-2572 ISBN-13:978-1-4471-1364-5 (U.S.) This work is subject to copyright.
    [Show full text]
  • Paraffin Granuloma Associated with Buried Glans Penis-Induced Sexual and Voiding Dysfunction
    pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2017 August 35(2): 129-132 https://doi.org/10.5534/wjmh.2017.35.2.129 Case Report Paraffin Granuloma Associated with Buried Glans Penis-Induced Sexual and Voiding Dysfunction Wonhee Chon1, Ja Yun Koo1, Min Jung Park3, Kyung-Un Choi2, Hyun Jun Park1,3, Nam Cheol Park1,3 Departments of 1Urology and 2Pathology, Pusan National University School of Medicine, 3The Korea Institute for Public Sperm Bank, Busan, Korea A paraffinoma is a type of inflammatory lipogranuloma that develops after the injection of an artificial mineral oil, such as paraffin or silicon, into the foreskin or the subcutaneous tissue of the penis for the purpose of penis enlargement, cosmetics, or prosthesis. The authors experienced a case of macro-paraffinoma associated with sexual dysfunction, voiding dysfunction, and pain caused by a buried glans penis after a paraffin injection for penis enlargement that had been performed 35 years previously. Herein, this case is presented with a literature review. Key Words: Granuloma; Oils; Paraffin; Penis A paraffinoma is a type of inflammatory lipogranuloma because of tuberculous epididymitis [1,3]. that develops after the injection of an artificial mineral oil, However, various types of adverse effects were sub- such as paraffin or silicon, into the foreskin or the subcuta- sequently reported by several investigators, and such pro- neous tissue of the penis for the purpose of penis enlarge- cedures gradually became less common [3-6]. Paraffin in- ment, cosmetics, or prosthesis [1]. In particular, as this pro- jections display outcomes consistent with the purpose of cedure is performed illegally by non-medical personnel in the procedure in early stages, but over time, the foreign an unsterilized environment or with non-medical agents, matter migrates from the primary injection site to nearby cases of adverse effects, such as infection, skin necrosis, tissues or even along the inguinal lymphatic vessel.
    [Show full text]
  • A Systematic Review of Graft Augmentation Urethroplasty Techniques for the Treatment of Anterior Urethral Strictures
    EUROPEAN UROLOGY 59 (2011) 797–814 available at www.sciencedirect.com journal homepage: www.europeanurology.com Review – Reconstructive Urology A Systematic Review of Graft Augmentation Urethroplasty Techniques for the Treatment of Anterior Urethral Strictures Altaf Mangera *, Jacob M. Patterson, Christopher R. Chapple Royal Hallamshire Hospital, Sheffield, United Kingdom Article info Abstract Article history: Context: Reconstructive surgeons who perform urethroplasty have a variety of Accepted February 2, 2011 techniques in their armamentarium that may be used according to factors such as Published online ahead of aetiology, stricture position, and length. No one technique is recommended. print on February 11, 2011 Objective: Our aim was to assess the reported outcomes of the various techniques for graft augmentation urethroplasty according to site of surgery. Keywords: Evidence acquisition: We performed an updated systematic review of the Medline Augmentation urethroplasty literature from 1985 to date and classified the data according to the site of surgery Anterior urethral stricture and technique used. Data are also presented on the type of graft used and the Bulbar urethroplasty follow-up methodology used by each centre. Dorsal onlay bulbar Evidence synthesis: More than 2000 anterior urethroplasty procedures have been urethroplasty describedinthe literature.Whenconsidering the bulbar urethra there isnosignificant Ventral onlay bulbar difference between the average success rates of the dorsal and the ventral onlay urethroplasty procedures, 88.4% and 88.8% at42.2 and 34.4 moin 934 and 563 patients,respectively. Penile urethroplasty The lateral onlay technique has only been described in six patients and has a reported success rate of 83% at 77 mo. The Asopa and Palminteri techniques have been described in 89 and 53 patients with a success rate of 86.7% and 90.1% at 28.9 and 21.9 mo, respectively.
    [Show full text]
  • A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches
    cancers Review Urological Melanoma: A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches Gerardo Cazzato 1,*,† , Anna Colagrande 1,†, Antonietta Cimmino 1, Concetta Caporusso 1, Pragnell Mary Victoria Candance 1, Senia Maria Rosaria Trabucco 1, Marcello Zingarelli 2, Alfonso Lorusso 2, Maricla Marrone 3 , Alessandra Stellacci 3 , Francesca Arezzo 4, Andrea Marzullo 1, Gabriella Serio 1, Angela Filoni 5, Domenico Bonamonte 5, Paolo Romita 5, Caterina Foti 5, Teresa Lettini 1 , Vera Loizzi 4, Gennaro Cormio 4 , Leonardo Resta 1 , Roberta Rossi 1,‡ and Giuseppe Ingravallo 1,‡ 1 Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (A.C.); [email protected] (A.C.); [email protected] (C.C.); [email protected] (P.M.V.C.); [email protected] (S.M.R.T.); [email protected] (A.M.); [email protected] (G.S.); [email protected] (T.L.); [email protected] (L.R.); [email protected] (R.R.); [email protected] (G.I.) 2 Section of Urology, Deparment of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (M.Z.); [email protected] (A.L.) 3 Section of Legal Medicine, Interdisciplinary Department of Medicine, Bari Policlinico Hospital, Citation: Cazzato, G.; Colagrande, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (M.M.); A.; Cimmino, A.; Caporusso, C.; [email protected] (A.S.) Candance, P.M.V.; Trabucco, S.M.R.; 4 Section of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, Zingarelli, M.; Lorusso, A.; Marrone, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (F.A.); M.; Stellacci, A.; et al.
    [Show full text]
  • Efficacy of Revision Urethroplasty in the Treatment Of
    ORIGINAL ARTICLE Bali Medical Journal (Bali Med J) 2020, Volume 9, Number 1: 67-76 P-ISSN.2089-1180, E-ISSN.2302-2914 Efficacy of revision urethroplasty in the treatment of ORIGINAL ARTICLE recurrent urethral strictures at a tertiary hospital (Kenyatta National Hospital–KNH), in Nairobi Kenya: Published by DiscoverSys CrossMark Doi: http://dx.doi.org/10.15562/bmj.v9i1.1675 2015-2018 Willy H. Otele,* Sammy Miima, Francis Owilla, Simeon Monda Volume No.: 9 ABSTRACT Issue: 1 Background: Urethral strictures cause malfunction of the urethra. while Subsidiary outcome measures were associated complications. Urethroplasty is a cost-effective treatment option. Its success rate Outcomes were compared using statistical package SPSS version 23.0. is greater than 90% where excision and primary anastomosis(EPA) Result: 235 patients who met inclusion criteria underwent is performed and 80-85% following substitution urethroplasty. urethroplasty, 71.5% (n=168) had a successful outcome, while28.5% First page No.: 67 Definitive treatment for recurrent urethral strictures after (n=67) failed and were subjected to revision urethroplasty. Another urethroplasty is not defined. Repeat urethroplasty is a viable option 58% were successful upon revision but experienced significant with unknown efficacy. morbidity. Majority of urethral strictures were bulbomembranous. P-ISSN.2089-1180 Method: Retrospective analysis of patients who underwent revision Trauma was the leading cause of urethral strictures followed by urethroplasty for unsuccessful urethroplasty at KNH from 2015 to idiopathic strictures. EPA was the commonest surgery while Tissue 2018 was performed. Patients’ age, demographic data, stricture transfer featured prominently in revision urethroplasty. A significant length, location, aetiology, comorbidities and type of urethroplasty correlation was evident between stricture length, prior surgery, and E-ISSN.2302-2914 was evaluated from records with complete data.
    [Show full text]
  • Vasectomy Reversal (VR)
    Vasectomy Reversal (VR) ! Need to know Please read this before your Vasectomy Reversal Preparing for the VR • Do not eat or drink after midnight if your operation is in the morning and not after 7.00am if it is in the afternoon. • Please shave the hair at the front and sides of the scrotum from the base of the penis down. You do not need to shave the pubic hair • Take supportive underpants (not your best) or a jockstrap into the hospital with you and to theatre to wear after the operation. • Arrange a week off work. • Avoid intercourse for two weeks after the operation and heavy lifting for four weeks. REF 0000.0 – 12/15 What to expect during the VR • An infection of the scrotum rarely occurs but if it does, • An incision is placed on each side of the scrotum that will present a few days after the surgery and is apparent are a little larger than those used for the vasectomy. because the pain becomes worse rather than better and the scrotum becomes red. • The vas is a very small muscular tube with a 2mm outer diameter and an inner diameter through which If you experience any of the above complications or sperm flow (the lumen), of less than 1/2mm. Since the have any other problem occur after your VR, please structure is so small, the stitches must be placed very call the Clinic or your Surgeon if outside clinic exactly so that there is minimal scarring. Too much hours. scarring can cause the lumen of the vas to close and the procedure to fail.
    [Show full text]
  • Evaluation and Treatment of Acute Urinary Retention
    The Journal of Emergency Medicine, Vol. 35, No. 2, pp. 193–198, 2008 Copyright © 2008 Elsevier Inc. Printed in the USA. All rights reserved 0736-4679/08 $–see front matter doi:10.1016/j.jemermed.2007.06.039 Technical Tips EVALUATION AND TREATMENT OF ACUTE URINARY RETENTION Gary M. Vilke, MD,* Jacob W. Ufberg, MD,† Richard A. Harrigan, MD,† and Theodore C. Chan, MD* *Department of Emergency Medicine, University of California, San Diego Medical Center, San Diego, California and †Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania Reprint Address: Gary M. Vilke, MD, Department of Emergency Medicine, UC San Diego Medical Center, 200 West Arbor Drive Mailcode #8676, San Diego, CA 92103 e Abstract—Acute urinary retention is a common presen- ETIOLOGY OF ACUTE URINARY RETENTION tation to the Emergency Department and is often simply treated with placement of a Foley catheter. However, var- Acute obstruction of urinary outflow is most often the ious cases will arise when this will not remedy the retention result of physical blockages or by urinary retention and more aggressive measures will be needed, particularly caused by medications. The most common cause of acute if emergent urological consultation is not available. This urinary obstruction continues to be benign prostatic hy- article will review the causes of urinary obstruction and pertrophy, with other obstructive causes listed in Table 1 systematically review emergent techniques and procedures (4). Common medications that can result in acute
    [Show full text]
  • And Ventral Buccal Mucosal Onlay (7 Days) Urethroplasty
    Clinical Urology EARLY CATHETER REMOVAL AFTER URETHROPLASTY International Braz J Urol Vol. 31 (5): 459-464, September - October, 2005 Official Journal of the Brazilian Society of Urology EARLY CATHETER REMOVAL AFTER ANTERIOR ANASTOMOTIC (3 DAYS) AND VENTRAL BUCCAL MUCOSAL ONLAY (7 DAYS) URETHROPLASTY HOSAM S. AL-QUDAH, ANDRE G. CAVALCANTI, RICHARD A. SANTUCCI Department of Urology (HSAQ, RAS), Wayne State University School of Medicine, Detroit, Michigan, USA, and Section of Urology (AGC), Souza Aguiar Municipal Hospital, Rio de Janeiro, Brazil ABSTRACT Introduction: Physicians who perform urethroplasty have varying opinions about when the urinary catheter should be removed post-operatively, but research on this subject has not yet appeared in the literature. We performed voiding cystourethrogram (VCUG) on our anterior urethroplasty pa- tients on days 3 (anastomotic) and 7 (buccal) in an effort to determine the earliest day for removal of the urethral catheter. Materials and Methods: Retrospective chart review of 29 urethroplasty patients from Octo- ber 2002 - August 2004 was performed at two reconstructive urology centers. 17 patients had early catheter removal (12 anastomotic and 5 ventral buccal onlay urethroplasty) and were compared to 12 who had late removal (7 anastomotic and 5 buccal). Results: Of those with early catheter removal, 2/12 (17%) of anastomotic urethroplasty pa- tients had extravasation, which resolved by the following week and 0/5 (0%) of the buccal mucosal urethroplasty patients had extravasation. Patients with late catheter removal underwent VCUG 6-14 days (mean 8 days) after anastomotic urethroplasty and 9-14 days (mean 12 days) after buccal mu- cosal urethroplasty. 0% of the anastomotic urethroplasty had leakage after the late VCUG and 1/5 (20%) of the buccal patients had extravasation after the VCUG.
    [Show full text]